Clinical Trials: Will Older Patients Finally Be Adequately Represented?

Would you want your doctor to prescribe a drug even though she did not know how it would affect you? Of course not. But this is exactly what happens all too often with older patients, given that many drugs and other therapies have not been tested on people beyond a certain age. In fact, one study found that 72% of clinical trials excluded patients due to age. With older adults being so underrepresented in clinical trials, clinicians often don’t know …

The Takeaway: Pfizer Alzheimer’s Drug Fails Late-Stage Study

An experimental treatment for Alzheimer's disease has turned out to be a disappointment in the first finished late-stage study, manufacturer Pfizer said Monday. Called bapineuzumab, it's one of three Alzheimer's treatments currently in clinical trials that some have been calling our "last hope" for drugs that slow the progression of the disease.